Archives: Presentations
Presentations
A Randomized Phase 2 Clinical Trial of Phentolamine Mesylate Eye Drops in Patients with Severe Night Vision Disturbances
Eye on the Cure Podcast: Ash Jayagopal, PhD Interview
Relative preservation of the extramacular retina in LCA5-associated Leber congenital amaurosis
Reduced nuclear NAD+ drives DNA damage and subsequent immune activation in the retina
Brown et al., Human Molecular Genetics 2021
Gene Therapy for Rdh12-Associated Retinal Diseases Helps to Delay Retinal Degeneration and Vision Loss
Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration
Greenwald et al., Human Molecular Genetics 2021
Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration
Greenwald et al., Molecular Therapy: Methods and Clinical Development, 2020
Treatment Potential for LCA5-Associated Leber Congenital Amaurosis
Uyhazi et al., Investigative Ophthalmology and Visual Science 2020
